National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

brequinar
A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This agent may also enhance the in vivo antitumor effect of antineoplastic agents such as 5-FU. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Bipenquinate
Chemical structure name:6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid



Previous:bortezomib, bosutinib, Boswellia serrata extract, Bowman-Birk inhibitor concentrate, Brassica vegetable
Next:brivanib alaninate, broad-spectrum human papillomavirus vaccine V505, broccoli sprout extract, bromelain, bromocriptine mesylate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov